A study listed on ClinicalTrials.gov.

This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.

Key inclusion criteria

• ≥18 to ≤45 years of age at Visit 1.
• BMI ≥18.5 and \<30.0 kg/m2 at Visit 1.
• Fasting capillary glucose ≤110 mg/dL at Visit 1.
• Willing to avoid consuming high-polyphenol containing foods for 48 hours prior to each test visit.
• Willing to abstain from alcohol consumption for 24 hours prior to each study visit.

Key exclusion criteria

• History or presence of clinically important cardiac, renal, hepatic, endocrine, pulmonary, biliary, pancreatic, gastrointestinal, or neurological disorders that may affect the participant's ability to adhere to the study protocol and/or affect study outcomes, in the judgment of the Clinical Investigator.
• Uncontrolled hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg) as defined by the blood pressure measured at Visit 1 (Section 9.1.1).
• Unstable use (initiation or change in dose) within 30 days of Visit 1 of antihypertensive medications.
• Unstable use (initiation or change in dose) within 30 days of Visit 1 of thyroid hormone replacement medications.
• Use of medications or supplements that may influence carbohydrate metabolism within 30 days of Visit 1.